financetom
Business
financetom
/
Business
/
Update: Netflix Q4 Earnings, Revenue Rise; Q1 Outlook Above Consensus; Shares Soar Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Netflix Q4 Earnings, Revenue Rise; Q1 Outlook Above Consensus; Shares Soar Premarket
Jan 22, 2025 2:18 AM

05:10 AM EST, 01/22/2025 (MT Newswires) -- (Updates with the stock move in headline, first paragraph.)

Netflix ( NFLX ) shares were up more than 14% in premarket activity on Wednesday after the company overnight reported a year-over-year jump in Q4 earnings and sales and above-consensus Q1 guidance.

The company reported Q4 earnings late Tuesday of $4.27 per diluted share, up from $2.11 a year earlier.

Analysts polled by FactSet expected $4.21.

Revenue for the quarter ended Dec. 31 was $10.25 billion, up from $8.83 billion a year earlier.

Analysts surveyed by FactSet expected $10.11 billion.

The company expects Q1 diluted EPS of $5.58 on revenue of $10.42 billion.

Analysts polled by FactSet expect EPS of $5.97 on revenue of $10.49 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca to buy EsoBiotec for up to $1 billion
AstraZeneca to buy EsoBiotec for up to $1 billion
Mar 17, 2025
(Reuters) -Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec's Engineered NanoBody Lentiviral (ENaBL) platform can genetically modify immune cells directly inside the body, allowing transformative cell therapy treatments in just minutes instead of the current process which takes weeks, AstraZeneca ( AZN ) said. AstraZeneca ( AZN ) will buy all...
Palantir Technologies Insider Sold Shares Worth $310,248,337, According to a Recent SEC Filing
Palantir Technologies Insider Sold Shares Worth $310,248,337, According to a Recent SEC Filing
Mar 17, 2025
03:29 AM EDT, 03/17/2025 (MT Newswires) -- Stephen Andrew Cohen, Director, President and Secretary, on March 12, 2025, sold 3,750,000 shares in Palantir Technologies ( PLTR ) for $310,248,337. Following the Form 4 filing with the SEC, Cohen has control over a total of 592 Class A common shares of the company, with 592 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1321655/000132165525000038/xslF345X05/wk-form4_1741998814.xml...
Energean says regulatory approvals delay puts Carlyle deal at risk
Energean says regulatory approvals delay puts Carlyle deal at risk
Mar 17, 2025
March 17 (Reuters) - Energean ( EERGF ) said on Monday Carlyle had not yet obtained regulatory approvals in Italy and Egypt for its proposed acquisition of some assets of the gas producer. The failure to meet these conditions may lead to the termination of the deal unless an extension is granted, Energean ( EERGF ) added. ...
Monster Beverage Insider Sold Shares Worth $2,585,940, According to a Recent SEC Filing
Monster Beverage Insider Sold Shares Worth $2,585,940, According to a Recent SEC Filing
Mar 17, 2025
03:28 AM EDT, 03/17/2025 (MT Newswires) -- Guy Carling, President of EMEA & OSP, on March 12, 2025, sold 47,000 shares in Monster Beverage ( MNST ) for $2,585,940. Following the Form 4 filing with the SEC, Carling has control over a total of 21,993 common shares of the company, with 21,993 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/865752/000086575225000030/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved